secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evolent Health, Inc. (EVH)
CIK:        0001628908
Form:       8-K
Filed at:   2025-06-03T23:59:59+00:00
Accession:  0001628908-25-000069
Event type: other_material
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Evolent Health reaffirms FY2025 revenue guidance of $2.06B-$2.11B at William Blair conference
--------------------------------------------------------------------------------

- Reaffirms FY2025 revenue guidance of $2.06B-$2.11B and Adjusted EBITDA of $135M-$165M.
- Q2 2025 revenue guidance reaffirmed at $440M-$470M; Adj EBITDA $33M-$40M.
- Guidance unchanged from the May 8, 2025 press release; no new financial targets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000069/0001628908-25-000069-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628908/000162890825000069/evh-20250603.htm
  HTML page:      https://secwatch.observer/filing/0001628908-25-000069

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer